Elevated Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Elevated Capital Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08M	Sell	4,263 -1,824	-30%	-$425K	0.3%	72
2026 Q1	$1.49M	Sell	6,087 -1,676	-22%	-$390K	0.37%	66
2025 Q4	$1.61M	Buy	7,763 +1,410	+22%	+$279K	0.37%	71
2025 Q3	$1.18M	Buy	6,353 +1,496	+31%	+$256K	0.29%	88
2025 Q2	$805K	Hold	4,857	–	–	0.23%	132
2025 Q1	$805K	Sell	4,857 -121	-2%	-$18.9K	0.23%	132
2024 Q4	$720K	Buy	4,978 +1,244	+33%	+$193K	0.2%	148
2024 Q3	$605K	Buy	+3,734	New	+$595K	0.16%	188

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Elevated Capital Advisors's JNJ Position: Q2 2026 in Review

Elevated Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 30% in Q2 2026, selling an estimated $425K and leaving 4,263 shares worth $1.08M. The position accounts for 0.3% of the portfolio, ranked #72.

Elevated Capital Advisors first reported a position in JNJ in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.61M in Q4 2025. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Elevated Capital Advisors held 4,263 shares of Johnson & Johnson worth $1.08M as of Q2 2026.
Elevated Capital Advisors sold 1,824 Johnson & Johnson shares in Q2 2026, an estimated $425K.
Johnson & Johnson made up 0.3% of Elevated Capital Advisors's portfolio in Q2 2026, its #72 holding.
Elevated Capital Advisors first reported a position in Johnson & Johnson in Q3 2024 and has held it in 8 quarters since.
Elevated Capital Advisors's Johnson & Johnson position peaked at $1.61M in Q4 2025.
4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Elevated Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.